Abstract
Purpose
Since there is no information regarding quality of life of caregivers assisting patients with advanced malignancy on home parenteral nutrition, herewith we report a preliminary series of 19 patients who received total parenteral nutrition at home under the strict supervision of their relatives.
Methods
The relatives of 19 incurable patients with cancer-related cachexia, discharged from the hospital with a home parenteral nutrition program, were prospectively studied. They filled out a validated questionnaire, the Family Strain Questionnaire Short Form, prior to patient discharge and after 2 weeks of home care. The questionnaire included 30 items, which explored different domains regarding the superimposed burden on caregivers in relation to the assistance given to their relatives.
Results
Our findings show that the basal level of strain was relatively high (about three quarters of positive answers) but did not increase after 2 weeks of home care. Similarly, there was no difference in the nutritional status and quality of life of the patients. Eight patients and their relatives could be also analyzed after 2 months and the results maintained unchanged.
Conclusion
This preliminary investigation shows that home parenteral nutrition does not exacerbate the level of strain on caregivers involved in surveillance of such a supportive intervention. It is possible that the perception of an active contribution to the benefit of patients, who maintained unchanged their nutritional status and quality of life, could gratify caregivers despite the objective burden in the constant supervision of administering Parenteral Nutrition.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The recent European Society of Nutrition and Metabolism (ESPEN) Guidelines on Nutrition in Oncology [1] strongly recommend (C6-2) that, apart from considering the expected benefit on patient survival and quality of life, take into account the indication for nutritional support of patients with advanced cancer also contemplating the potential burden of such treatment.
There is some evidence from prospective studies that parenteral nutrition can have some benefit in survival, especially in some incurable patients who would die prior from starvation than from tumor growth, and now a nomogram is available to estimate the life expectancy of patients on home parenteral nutrition (HPN), depending on some prognostic variables [2, 3]. Data on quality of life (QoL) [4] are definitely scanty and show stable QoL scores during HPN, with a decline in the last 2–3 months before death. On the contrary, the information on the potential psychologic and physical burden that HPN management causes on the family caregivers is totally lacking.
Indeed, this is a relevant issue not only in perspective of a modern comprehensive view of medical care, including the patient-family unit, [5] but also because a family caregiver, per se, appears to be extremely important for the QoL of patients on HPN [6].
The aim of this paper is to report preliminary data on the acute impact, on the family caregivers, of the HPN program management in incurable cancer patients.
Patients and methods
We report data of a subset of 19 incurable patients with cancer cachexia, included in a prospective HPN database at the Internal Medicine and Clinical Nutrition Unit of the Federico II University Hospital, in Naples.
The daily nutritional regimen provided 30 non-protein kcal/kg/day and 1.34 g amino acid/kg/day, corresponding to 35 mL/kg/day of an all-in-one nutritional emulsion (Nutriplus Lipid or Nutriplus Omega, BBraun) that was administered through a central venous catheter (CVC), generally already implanted for chemotherapy. The time of daily infusion was set from14 to 18 h, preferably by the use of an infusion pump.
The nutrition team provided patients and/or their caregivers with oral and written instructions regarding home management for nutritional therapy and how to recognize the main potential CVC-related complications [7]. The practical training session lasted 30 min, after which each participant was given a brochure containing detailed written instructions with complete explanatory illustrations on the correct CVC management (sterile devices for the application of nutritional therapy, times and modalities for dressings, etc.…) including also first aid of potential complications.
The nutritional team was available by telephone from Monday to Friday, 8:30 a.m. to 5:00 p.m., followed by a 24 h availability of an Internal Medicine ward physician. Finally, a periodical (biweekly or according to the patient’s needs) follow-up of the patient’s clinical conditions as well as of routine haemato-biochemical values was performed.
We assessed the caregiver-related problems through the Family Strain Questionnaire-Short Form (FSQ-SF). The FSQ originally consisted of a brief semi-structured interview and 44 dichotomic items that explored the following five domains: emotional burden, problems in social involvement, the necessity of knowledge about the disease, family relationships satisfaction, and thoughts about death. Its validity and reliability were assessed in 818 caregivers (314 were involved with the care of oncologic patients) and were defined good [8]. However, we used the short form of this validated questionnaire, which includes thirty “yes-no” items selected from a previous list (Table 1). This version demonstrated to have very good fit statistics and to maintain the diagnostic qualities of the original form. The FSQ-SF [8] could be completed by caregivers in approximately 10 minutes and filled out at the first visit, after 2 weeks and after 1 and 2 months for surviving patients. The FSQ-SF items are reported in Table 1. The number of “yes” answers for questions 1–30 is counted; the higher the number of “yes”, the more severe the caregivers’ strain.
The statistical analysis was performed using the Statistical Package for Social Sciences (version 15.0 for Windows). Results are expressed as means ± SD, unless otherwise stated. Student’s T test was used for mean comparison. Significance was set at p ≤ 0.05.
The Ethical Local Committee approved the research (protocol number 124/12) and informed consent was achieved by all participants to the study.
Results
There were 19, 59 ± 9.0 years old (9 males, 10 women), patients with late-stage adenocarcinoma of the ovary (8 patients), stomach (4 patients), colon-rectum (3 patients), pancreas (2 patients), and gallbladder (1 patient). Patients were severely malnourished, their body weight being kg 50.5 ± 8.6, the weight loss (WL) being kg 11.8 ± 4.5 (23.5% ± 8.1 of the usual body weight) in the previous 6 months.
Patients can be defined cachectic according to the recent definitions of cachexia, which consider a WL ≥ 10% and systemic symptoms [9] or a WL > 5% or BMI < 20 + WL > 2% [10].
Their measured resting energy expenditure was 1217 ± 210 kcal/day, and respiratory quotient was 0.71 ± 0.23. Mean survival was 73.7 ± 45.5 days.
The biochemical markers did not change, significantly, as an indicator for the lack of toxicity of the HPN (data not shown).
The caregivers who completed the questionnaire were daughters (n.7), husbands (n.6), sons (n.3), wives (n.2), and one mother. Data show that FSQ-SF total “yes” answers were initially 22 (median; range 22–28) and at 2 weeks were 23 (median; range22–28) (Fig. 1). Similarly, there was no change in nutritional parameters (anthropometrics, biochemical, immunologic, functional, and those pertinent to QoL) of the patients. The time course of variables for eight survivors after 1 and 2 months of HPN was also evaluated; no significant differences emerged at the different time points both in patients and their caregivers (data not shown).
Discussion
There is a fair amount of literature [11,12,13,14,15,16,17,18,19,20,21,22] investigating the impact of disease on the lives of families of patients with cancer, but, so far, no study has considered the strain of family members involved in the management of HPN for their relatives, despite this procedure may be quite demanding and may result difficult for patients themselves and their families.
It is noteworthy that the vast majority of published studies focus on the affective burden that the disease per se imposes on family members-caregivers; whereas, in patients on HPN, caregivers have a double burden because they are also involved 24 h daily in the surveillance of a proper HPN administration.
The HPN program indications mainly relied on the assumption that aphagic cancer patients (usually for malignant sub/obstruction) would earlier succumb due to starvation than tumor growth. Previous experiences [23, 24] have shown that a similar group of patients discharged without any nutritional support can survive only very few weeks at home; hence, it was considered a reasonable option to plan a HPN program in such patients, provided they were not judged to be in a phase of rapidly progressing disease.
We were solicited to present preliminary data on QoL of caregivers’ assisting incurable cancer patients on HPN for two reasons. Firstly, because the current ESPEN recommendations on HPN in advanced cancer patients have a “low level of evidence” [1] and secondly, because there was a specific suggestion of further investigation in this area on behalf of the ESPEN guideline committee experts [1].
Results showed that the basal strain level of caregivers was already considerably high (“yes” answers equivalent to three quarters) probably due to the fact that family members were already long-dealing with a dramatic progressive trajectory towards the death of their relatives; of note, the strain level did not increase when involved in managing HPN. The low number of patients and caregivers recruited in our study is certainly a limitation; nevertheless, the results are quite homogeneous, and hence, it is unlikely that results might change by increasing the number of the caregivers investigated. Considering the fact that the overall experience demonstrated that individuals over time tend to progressively cope with adverse events, it is also unlikely that caregivers positively facing the initial acute burden of HPN administration would later become more stressed once the procedure is familiar and easy.
Indeed, we could hypothesize that caregivers might even be somewhat gratified by their involvement in what they deem essential for the survival of their relatives, consequently possibly mitigating the effort needed to manage HPN.
This is in keeping with the observations of Orrevall et al. [25] who described in 13 cancer patients that the most salient positive features of HPN were in relation to a sense of relief and security, furthermore, that nutritional needs were met and both patients and family members reported the experience as having a direct and positive effect on QoL. In fact, nourishment, also the intravenous one, has a cultural and symbolic value and is experienced by the family caregiver as an expression of love and care for the severely ill relative. While physicians tend to see nourishment as a “medical treatment” aimed at achieving physiological objectives (and this is the official position of many Scientific Societies), families see feeding as an “act of community” [26]. Likewise, it is noteworthy that caregivers possibly realized that HPN was somewhat effective in maintaining their relatives in a steady state. De facto, these patients had a measured resting energy expenditure of about 24 kcal/kg; hence, their total energy expenditure was expected to be about 31.3 kcal/kg [22] and was well covered by a daily HPN regimen providing them 35 kcal/kg. This is in accordance with our previous experience [3, 27] and reflects the adequacy of the HPN nutritional regimen.
Lastly, it should be also considered that QoL of patients on HPN declines in the last weeks of life [3], and hence, the QoL score maintenance at stable levels must be viewed as a positive result.
In conclusion, these preliminary data, which warrant a further confirmation on larger prospective studies, show that the level of strain was high in familial caregivers of patients with incurable cancer, but no worsening was seen when involved in the HPN management. This may also indirectly translate into a benefit of QoL of the patients themselves [6].
References
Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC (2016) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11–48
Bozzetti F, Santarpia L, Pironi L, Thul P, Klek S, Gavazzi C, Tinivella M, Joly F, Jonkers C, Baxter J, Gramlich L, Chicharro L, Staun M, Van Gossum A, Lo Vullo S, Mariani L (2014) The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann Oncol 25(2):487–493
Bozzetti F, Cotogni P, Lo Vullo S, Pironi L, Giardiello D, Mariani L (2015) Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition. Ann Oncol 26(11):2335–2340
Bozzetti F, Cozzaglio L, Biganzoli E, Chiavenna G, De Cicco M, Donati D, Gilli G, Percolla S, Pironi L (2002) Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr 21(4):281–288
Nguyen TK, Bauman GS, Watling CJ, Hahn K (2017) Patient- and family-centered care: a qualitative exploration of oncologist perspectives. Support Care Cancer 25(1):213–219
Joly F, Baxter J, Staun M, Kelly DG, Hwa YL, Corcos O, De Francesco A, Agostini F, Klek S, Santarpia L, Contaldo F, Jonker C, Wanten G, Chicharro L, Burgos R, Van Gossum A, Cuerda C, Virgili N, Pironi L; ESPEN HAN CIF group (2017). Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure. Clin Nutr. https://doi.org/10.1016/j.clnu.2017.06.016
Santarpia L, Pasanisi F, Alfonsi L, Violante G, Tiseo D, De Simone G, Contaldo F (2002) Prevention and treatment of implanted central venous catheter (CVC)-related sepsis: a report after six years of home parenteral nutrition (HPN). Clin Nutr 21(3):207–211
Rossi Ferrario S, Baiardi P, Zotti AM (2004) Update on the family strain questionnaire: a tool for the general screening of caregiving-related problems. Qual Life Res 13(8):1425–1434
Bozzetti F, Mariani L (2009) Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. JPEN J Parenter Enteral Nutr 33(4):361–367
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489–495
Vidotto G, Ferrario SR, Bond TG, Zotti AM (2010) Family strain questionnaire-short form for nurses and general practitioners. J Clin Nurs 19(1–2):275–283
Cohen R, Leis AM, Kuhl D, Charbonneau C, Ritvo P, Ashbury FD (2006) QOLLTI-F: measuring family carer quality of life. Palliat Med 20:755–767
Hagedoorn M, Buunk BP, Kuijer RG, Wobbes T, Sanderman R (2000) Couples dealing with cancer: role and gender differences regarding psychological distress and QOL. Psycho Oncol 9:232–242
Koldjeski D, Kirkpatrick MK, Everett L, Brown S, Swanson M (2007) The ovarian cancer journey of families the first postdiagnostic year. Cancer Nurs 30:232–242
Lewis FM (1986) The impact of cancer on the family: a critical analysis of the research literature. Patient Educ Couns 8:269–289
Mellon S (2002) Comparisons between cancer survivors and family members on meaning of the illness and family quality of life. Oncol Nurs Forum 29:1117–1125
Northouse LL, Mood D, Templin T, Mellon S, George T (2000) Couples’ patterns of adjustment to colon cancer. Soc Sci Med 50:271–284
Osse BHP, Vernooij-Dassen MJFJ, Schade E, Grol RPTM (2006) Problems experienced by the informal caregivers of cancer patients and their needs for support. Cancer Nurs 29:378–388
Papadopoulos A, Vrettos I, Kamposioras K et al (2011) Impact of cancer patients’ disease awareness on their family members’ health-related quality of life: a cross-sectional survey. Psycho Oncol 20(3):294–301
Pitceathly C, Maguire P (2003) The psychological impact of cancer on patients’ partners and other key relatives: a review. Eur J Cancer 39:1517–1524
Swanberg JE (2006) Making it work: informal caregiving, cancer, and employment. J Psychosoc Oncol 24:1–18
Weitzner MA, Jacobsen PB, Wagner H, Friedland JJ, Cox C (1999) The Caregiver Quality of Life Index–Cancer (CQOLC) scale: development and validation of an instrument to measure quality of life of the family caregiver of patients with cancer. Qual Life Res 8:55–63
Mercadante S (1995) Bowel obstruction in home-care cancer patients: 4 years experience. Support Care Cancer 3(3):190–193
Porzio G, Aielli F, Verna L, Galletti B, Shoja E, Razavi G, Ficorella C (2011) Can malignant bowel obstruction in advanced cancer patients be treated at home? Support Care Cancer 19(3):431–433
Orrevall Y, Tishelman C, Permert J (2005) Home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr 24(6):961–970
Miles SH (1989) Nourishment and the ethics of lament. Linacre Q 56(3):64–69
Bozzetti F, Ammatuna M, Migliavacca S, Bonalumi MG, Facchetti G, Pupa A, Terno G (1987) Total parenteral nutrition prevents further nutritional deterioration in patients with cancer cachexia. Ann Surg 205(2):138–143
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Santarpia, L., Bozzetti, F. Acute impact of home parenteral nutrition in patients with late-stage cancer on family caregivers: preliminary data. Support Care Cancer 26, 667–671 (2018). https://doi.org/10.1007/s00520-017-3884-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-017-3884-4